COLL vs DG · P/E 17, rev $181.9M vs P/E 15, rev $40.61B
Collegium Pharmaceutical Inc (COLL) versus Dollar General Corporation (DG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Dollar General Corporation (DG) is a discount stores company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Not investment advice. Open the COLL and DG stock pages for the full models.
Not investment advice.